KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Net Cash Flow (2020 - 2025)

Oscar Health (OSCR) has disclosed Net Cash Flow for 6 consecutive years, with $671.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Cash Flow rose 110.5% year-over-year to $671.9 million, compared with a TTM value of $1.3 billion through Dec 2025, up 479.5%, and an annual FY2025 reading of $1.1 billion, up 421.21% over the prior year.
  • Net Cash Flow was $671.9 million for Q4 2025 at Oscar Health, up from -$450.5 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $1.5 billion in Q1 2021 and bottomed at -$1.1 billion in Q3 2024.
  • Average Net Cash Flow over 5 years is $100.1 million, with a median of $253.2 million recorded in 2022.
  • The sharpest move saw Net Cash Flow skyrocketed 865.71% in 2021, then tumbled 2108.9% in 2022.
  • Year by year, Net Cash Flow stood at $27.6 million in 2021, then crashed by 2108.9% to -$554.8 million in 2022, then surged by 184.8% to $470.4 million in 2023, then plummeted by 32.15% to $319.2 million in 2024, then surged by 110.5% to $671.9 million in 2025.
  • Business Quant data shows Net Cash Flow for OSCR at $671.9 million in Q4 2025, -$450.5 million in Q3 2025, and $363.0 million in Q2 2025.